Products

ClariPulmo
ClariPi Inc.
Oncology AI
ClariPulmo is a non-invasive image analysis software for use with CT images which is intended to support the quantification of lung CT images. The software is designed to support the physician in the diagnosis and documentation of pulmonary tissue images (e.g., abnormalities) from the CT thoracic datasets.
ClariSIGMAM
ClariPi Inc.
Oncology AI
ClariSIGMAM is an AI-powered breast density assessment solution by ClariPi that provides accurate and consistent density estimates from digital mammograms, aiding radiologists in breast tissue composition assessment and breast cancer risk prediction.
ClariCT.AI
ClariPi Inc.
Radiology & Imaging AI
ClariCT.

See all 3 products →

About ClariPi

ClariPi is a South Korean healthcare AI company founded in February 2015, specializing in innovative solutions for unmet needs in medical imaging. The company integrates intelligent big data computing and medical imaging technologies to develop products that assist medical imaging experts in making confident decisions with clearer information and convenient decision guidance. Their solutions are designed to help medical professionals navigate the evolving landscape of 21st-century healthcare services, with a strong emphasis on improving image quality and radiation safety.

ClariPi’s flagship product, ClariCT.AI, is a vendor-neutral CT denoising solution powered by deep learning. It aims to enhance image clarity in CT examinations, particularly for ultra-low-dose scans, by reducing noise and artifacts while preserving anatomical structures. This technology allows for lower radiation doses without compromising diagnostic image quality, addressing concerns about radiation exposure from CT scans. Beyond ClariCT.AI, ClariPi is actively developing other AI-powered diagnostic solutions for conditions such as emphysema (ClariPulmo), breast density assessment (ClariSIGMAM), abdominal metabolic syndrome, and liver fat.

Focus Areas

AI medical imaging CT image denoising lung disease analysis breast density assessment metabolic risk quantification bone mineral density AI contrast enhancement ultra-low-dose CT

Business Intelligence

TechnologyDeep learning, convolutional neural networks, big data technology, cloud-native, DICOM protocols, vendor-neutral software

What Physicians Need to Know

CT Image Denoising & Ultra-Low-Dose CT
ClariPi's flagship product, ClariCT.AI, utilizes deep learning and a deep convolutional neural network trained on over a million patient images to significantly reduce noise and enhance clarity in low-dose and ultra-low-dose CT scans. This allows for reduced radiation exposure for patients, extended lifespan of X-ray tubes, and improved image quality even from older CT scanners.
Lung Disease Analysis
ClariPulmo is an AI-powered tri-functional solution for lung CT images, offering automated segmentation and visualization of lungs and airways, emphysema reporting, and quantification of low-attenuation (LAA) and high-attenuation (HAA) lesions. It can be combined with ClariCT.AI for noise reduction and 3D reporting, aiding in the diagnosis and documentation of pulmonary tissue images.
Breast Density Assessment
ClariSIGMAM is an AI-powered solution that provides accurate and consistent breast density estimates from standard digital mammograms. It automatically analyzes 2D digital mammograms to quantify breast tissue composition (fat and glandular tissue) and generates a BI-RADS density grade, addressing the subjectivity often found in manual assessments.
Metabolic Risk Quantification
ClariAdipo automatically measures subcutaneous and visceral fat density on abdominal CT images using AI deep learning technology. It classifies patients into five metabolic risk levels, providing structured fat metrics to help predict the risk of developing metabolic syndrome.
Bone Mineral Density & Fracture Risk
ClariOsteo is an AI-powered solution that utilizes existing low-dose CT scans to automatically detect vertebral compression fractures and measure bone mineral density, providing analysis reports on spine fracture and osteoporosis risks for prevention and treatment management.
AI Contrast Enhancement
ClariACE is the world's first AI-powered solution for augmented contrast enhancement in low-dose contrast-enhanced CT (CECT) images. It uses a deep learning model to selectively boost iodine contrast components without increasing noise, allowing for reduced iodine doses while maintaining diagnostic clarity.
Physician Tip

ClariPi's solutions are designed to enhance diagnostic confidence and workflow efficiency by providing clearer images from low-dose radiation scans. Physicians can benefit from reduced reading and diagnosis times, minimized patient callbacks for rescans, and improved accuracy in disease detection, especially in radiation-sensitive patients. The AI-powered tools offer objective and consistent quantitative analyses, such as breast density assessment and lung lesion quantification, which can reduce inter-reader variability. The ability to use ultra-low-dose CT without sacrificing image quality is a significant advantage for patient safety and managing radiation exposure.

ClariPi's products are DICOM compliant, ensuring seamless integration with existing CT equipment and PACS systems. Their software is vendor-agnostic, meaning it works with any brand and model of CT scanner. Solutions support real-time processing and can be deployed from desktop, embedded scanner, or cloud. ClariPi's software is also available through platforms like the Nuance AI Marketplace and Siemens Healthineers Digital Marketplace.

Products by ClariPi

3 products in the directory

ClariPulmo
ClariPi Inc.
Oncology AI
ClariPulmo is a non-invasive image analysis software for use with CT images which is intended to support the quantification of lung CT images. The software is designed to support the physician in the diagnosis and documentation of pulmonary tissue images (e.g., abnormalities) from the CT thoracic datasets.
ClariSIGMAM
ClariPi Inc.
Oncology AI
ClariSIGMAM is an AI-powered breast density assessment solution by ClariPi that provides accurate and consistent density estimates from digital mammograms, aiding radiologists in breast tissue composition assessment and breast cancer risk prediction.
ClariCT.AI
ClariPi Inc.
Radiology & Imaging AI
ClariCT.

Videos

News, demos, and interviews about ClariPi.

Loading videos...

Videos load interactively. If none appear, search YouTube for ClariPi →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

ClariPi specializes in AI-powered medical imaging solutions, including CT image denoising, lung disease analysis, breast density assessment, metabolic risk quantification, and bone mineral density assessment. Their products aim to enhance image quality and provide quantitative insights for various diagnostic needs.
ClariPi's AI contrast enhancement and denoising technologies are designed to improve the diagnostic quality of ultra-low-dose CT images. This helps mitigate concerns about reduced image quality and increased noise often associated with lower radiation doses, allowing for safer imaging protocols without compromising diagnostic accuracy.
ClariPi's products are developed with regulatory compliance in mind, though specific certifications may vary by product and region. For detailed information on regulatory approvals and pricing models, it is best to contact ClariPi directly as these can be tailored to individual institutional needs and regional requirements.
ClariPi typically offers comprehensive technical support and training programs to ensure seamless integration and effective utilization of their AI solutions within healthcare facilities. This includes assistance with installation, user training, and ongoing technical support to address any operational questions or issues.
ClariPi's AI solutions are generally designed for interoperability with existing Picture Archiving and Communication Systems (PACS) and Electronic Medical Record (EMR) systems. This ensures a streamlined workflow and easy access to AI-generated insights within your current clinical infrastructure.
ClariPi has established partnerships within the healthcare technology sector to further develop and distribute its AI solutions. As for company stability, ClariPi is an active player in the medical AI imaging market, continually innovating and expanding its product offerings.
ClariPi's AI algorithms for lung disease analysis and breast density assessment are developed using advanced machine learning techniques and extensive datasets to ensure high accuracy. While specific performance metrics can vary, their solutions aim to provide reliable and consistent quantitative assessments to aid in diagnosis and risk stratification.

Related Companies

Radin Health offers a comprehensive suite of AI-powered, cloud-based solutions designed to enhance operational efficiency across all stages of the radiology workflow. Their platform integrates a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-driven Dictation, and RADIN SELECT for workflow management. These solutions aim to improve efficiency and productivity for administrators, medical […]

Spectrum Dynamics Medical is a pioneering medical device company focused on transforming nuclear medicine from analog to digital technology. They specialize in developing high-definition, solid-state based nuclear imaging technology, including digital SPECT (Single Photon Emission Computed Tomography) and SPECT/CT systems. Their products aim to meet the clinical needs and workflow demands of diagnostic imaging departments […]

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Siemens Healthineers is a leading global medical technology company that pioneers breakthroughs in healthcare. The company focuses on medical technology and diagnostics, offering a wide range of products including imaging systems, laboratory diagnostics, and advanced therapies. Their innovations aim to improve patient outcomes and make healthcare more accessible and sustainable. Siemens Healthineers has a strong […]

Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.